BiOptic Inc. (TPEX:6850)
Taiwan · Delayed Price · Currency is TWD 33.50
+0.30 (0.90%)
Aug 26, 2026, 1:18 PM CST
BiOptic Market Cap
BiOptic has a market cap or net worth of 1.1 billion as of August 25, 2026. Its market cap has decreased by -29.06% in one year.
Market Cap
1.10B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
33.50
ChartMarket Cap Chart
Since November 10, 2021, BiOptic's market cap has decreased from 1.23B to 1.10B, a decrease of -10.83%. That is a compound annual growth rate of -2.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 25, 2026 | 1.13B | -14.57% |
| Dec 31, 2025 | 1.32B | 1.58% |
| Dec 31, 2024 | 1.30B | -2.59% |
| Dec 29, 2023 | 1.33B | 17.65% |
| Dec 30, 2022 | 1.13B | 7.14% |
| Dec 30, 2021 | 1.06B | -14.29% |
| Nov 10, 2021 | 1.23B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GenMont Biotech Incorporation | 1.37B |
| Abnova (Taiwan) | 1.26B |
| NeoCore Technology | 1.26B |
| Enimmune | 1.19B |
| U-Neuron Biomedical | 1.17B |
| LabTurbo Biotech | 1.12B |
| Bio Preventive Medicine | 1.09B |
| Level Biotechnology | 1.02B |